Search

Verorab

Verorab

rabies vaccine

Manufacturer:

Sanofi

Distributor:

Zuellig
/
Four Star
Concise Prescribing Info
Contents
Inactivated rabies vaccine
Indications/Uses
Pre- & post-exposure rabies prophylaxis in all age groups.
Click to view Verorab detailed prescribing information
Dosage/Direction for Use
IM Recommended dose: 0.5 mL of reconstituted vaccine. Pre-exposure prophylaxis Immunocompetent individual or individual w/ decreased immunity Conventional regimen: 1 dose on day 0, 7, & 21 or 28. Immunocompetent individual 1-wk regimen: 1 dose on day 0 & 7. Post-exposure prophylaxis Non-immunised subject or individual w/ decreased immunity Essen protocol: 1 dose on day 0, 3, 7, 14, & 28. Zagreb protocol: 2 doses on day 0; 1 dose on day 7 & 21. Immunised subject 1 dose on day 0 & 3. ID Recommended dose: 0.1 mL of reconstituted vaccine per inj site. Pre-exposure prophylaxis Immunocompetent individual 1-wk regimen: 2 doses on day 0 & 7. Post-exposure prophylaxis Non-immunised subject or individual w/ decreased immunity New Thailand Red Cross ID regimen: 2 doses on day 0, 3, 7, & 28. Institute Pasteur of Cambodia ID regimen: 2 doses on day 0, 3, & 7. 4-site 1-wk ID regimen: 4 doses on day 0, 3, & 7. Immunised subject 1 dose on day 0 & 3. Alternatively, 4 doses at 4 separate sites on day 0.
Click to view Verorab detailed prescribing information
Overdosage
View Verorab overdosage for action to be taken in the event of an overdose.
Contraindications
Pre-exposure: Hypersensitivity. Presence of fever or acute disease.
Click to view Verorab detailed prescribing information
Special Precautions
Do not administer via intravascular route. Appropriate medical treatment & supervision must be readily available in case of a rare anaphylactic reaction after vaccine administration. Caution in individuals w/ allergy to polymyxin B, streptomycin, neomycin or to any antibiotic of the same class. Perform serological tests in accordance w/ official recommendations. In case of immunodeficiency, perform blood tests 2-4 wk after vaccination to ensure protective immune response was obtained. Risk of bleeding during IM administration in subjects w/ thrombocytopenia or clotting disorders. Contains phenylalanine; may be harmful to phenylketonurics. Can temporarily affect ability to drive & use machines.
Click to view Verorab detailed prescribing information
Adverse Reactions
Generally feeling unwell; headache; muscle pain; pain, erythema, &/or swelling at the inj site; (only in babies) irritability, inconsolable crying & drowsiness. Fever; lymphadenopathy; allergic reactions eg, rash & itching; flu-like syndrome; pruritus &/or induration at the inj site; (only in babies) difficulty sleeping.
Drug Interactions
Corticosteroids & immunosuppressives may interfere w/ Ab production. Do not combine rabies Ig & rabies vaccine in the same syringe or administer at the same site.
Click to view Verorab detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Verorab detailed prescribing information
Storage
View Verorab storage conditions for details to ensure optimal shelf-life.
Description
View Verorab description for details of the chemical structure and excipients (inactive components).
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BG01 - rabies, inactivated, whole virus ; Belongs to the class of rabies viral vaccines.
Presentation/Packing
Form
Verorab vaccine (inj)
Packing/Price
(vial) 1 dose x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in